Conduit Pharmaceuticals Inc (CDT)

Stock price, financials, and technical signals for Conduit Pharmaceuticals Inc (CDT).

$2.55

-0.21

(-7.61%)

As of 01/31/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

CDT Performance Snapshot


1-Week Chg

-49.00%

1-Month Chg

-66.49%

3-Month Chg

-74.80%

6-Month Chg

-88.33%

1-Year Chg

-99.10%

Year-To-Date Chg

-66.31%

Beta 1-Year

-1.14

Beta 5-Year

2.13

Volatility (10-Day)

37.15%

CDT Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-01-31

$2.48

-$0.07 (-2.75%)

$2.54

$2.56

$2.35

$2.46

245.25K ($608.21K)

2025-01-30

$2.55

-$0.21 (-7.61%)

$2.74

$2.80

$2.44

$2.60

520.19K ($1.33M)

2025-01-29

$2.76

-$0.31 (-10.1%)

$2.85

$2.89

$2.51

$2.72

409.75K ($1.13M)

2025-01-28

$3.07

-$0.23 (-6.97%)

$3.73

$3.97

$3.01

$3.35

4.68M ($14.37M)

2025-01-27

$3.30

-$1.22 (-26.99%)

$3.71

$3.71

$2.94

$3.32

701.84K ($2.32M)

2025-01-24

$4.52

-$0.48 (-9.6%)

$4

$5.84

$4

$4.79

256.64K ($1.16M)

2025-01-23

$5

-$1.25 (-20%)

$4.98

$5.06

$4.57

$4.88

472.10K ($2.36M)

2025-01-22

$6.25

-$0.50 (-7.41%)

$6.93

$7.30

$6.20

$6.58

735.01K ($4.59M)

2025-01-21

$6.75

-$0.45 (-6.25%)

$7.27

$7.28

$6.50

$6.84

194.86K ($1.32M)

2025-01-17

$7.20

-$0.18 (-2.44%)

$7.49

$7.68

$6.70

$7.19

135.30K ($974.17K)

CDT Financials


Balance Sheet

(USD)

2024 Q3

Y/Y CHANGE


  • Cash and equivalents

    $71.00K

    -99.18%

  • Total assets

    $2.99M

    -75.10%

  • Total liabilities

    $12.11M

    -7.54%

  • Total investments

    $81.00K

    -

  • Shareholders' equity

    -$9.12M

    -743.48%

  • Book value per share

    -$0.10

    -517.65%


Income Statement

(USD)

2024 Q3

Y/Y CHANGE


  • Revenue

    $0

    0%

  • Net income

    -$6.46M

    -425.33%

  • Operating expense

    $5.81M

    443.59%

  • Gross profit

    $0

    0%

  • EBITDA

    -$6.15M

    -402.36%

  • Earnings per share

    -$0.07

    -333.33%


Cash Flow

(USD)

2024 Q3

Y/Y CHANGE


  • Net change in cash

    -$148.00K

    -101.71%

  • Cash from operations

    -$2.00M

    -281.49%

  • Cash from investing

    $96.00K

    -82.86%

  • Cash from financing

    $1.74M

    -79.77%

  • Free cash flow

    -$2.04M

    -289.31%

  • Free cash flow per share

    -$0.02

    -187.50%


Metrics

(USD)

2024 Q3

Y/Y CHANGE


  • Market capitalization

    $11.38M

    -97.38%

  • Enterprise value

    $12.43M

    -97.17%

  • Shares outstanding

    96.00M

    31.85%

  • Profit margin

    -

    -

  • Gross margin

    -

    -

  • EBITDA margin

    -

    -


Dividends

(USD)

2024 Q3

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    -

  • Coverage ratio

    -

    -

  • Current ratio

    0.12

    -94.84%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.